ホーム › 大腸癌 › アイオワ州 › Cedar Rapids
Cedar Rapids、IAにおける大腸癌の臨床試験
Cedar Rapidsとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
被験者募集中第2相
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
被験者募集中第1/2相
- University of Iowa Hospitals and Clinics, Iowa City · 25マイル先
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
被験者募集中第1/2相
- University of Iowa, Iowa City · 25マイル先
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
被験者募集中第3相
- University of Iowa Hospitals and Clinics, Iowa City · 25マイル先
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
被験者募集中第3相
- University of Iowa Hospital, Iowa City · 25マイル先
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
被験者募集中第2/3相
- University of Iowa, Iowa City · 25マイル先
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- University of Iowa Hospital and Clinics, Iowa City · 25マイル先
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
被験者募集中第1相
- University of Iowa Health Care, Iowa City · 25マイル先
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
被験者募集中第1相
- University of Iowa Hospitals & Clinics, Iowa City · 25マイル先
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
被験者募集中第3相健康なボランティア歓迎
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25マイル先
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
被験者募集中観察研究
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY78件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Philadelphia, PA44件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA37件の研究
- Chicago, IL34件の研究
Cedar Rapidsにおける他の研究
- 非小細胞肺癌20件の研究
- 乳がん17件の研究
- がん（全種類）16件の研究
- 急性骨髄性白血病16件の研究
- 多発性骨髄腫15件の研究
- 肺がん14件の研究
- 頭頸部扁平上皮癌12件の研究
- 前立腺がん12件の研究
- 脳卒中10件の研究
- 悪性黒色腫10件の研究
- 子宮内膜がん9件の研究
- 血液がん9件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。